RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Murali Yallapu to Amyotrophic Lateral Sclerosis

Back to Details
This is a "connection" page, showing publications Murali Yallapu has written about Amyotrophic Lateral Sclerosis.
Murali Yallapu
Connection Strength
0.808
Amyotrophic Lateral Sclerosis
  1. Dhasmana S, Dhasmana A, Khan S, Narula AS, Haque S, Yallapu MM, Chauhan SC. Excessive Urinary p75ecd is a Potential Indicator of Amyotrophic Lateral Sclerosis: An American Cohort Study. Curr Neuropharmacol. 2025; 23(12):1621-1630.
    View in: PubMed
    Score: 0.223
  2. Anilkumar AK, Vij P, Lopez S, Leslie SM, Doxtater K, Khan MM, Yallapu MM, Chauhan SC, Maestre GE, Tripathi MK. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases. Int J Mol Sci. 2024 Feb 14; 25(4).
    View in: PubMed
    Score: 0.210
  3. Dhasmana S, Dhasmana A, Kotnala S, Mangtani V, Narula AS, Haque S, Jaggi M, Yallapu MM, Chauhan SC. Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis. Curr Neuropharmacol. 2023; 21(5):1117-1138.
    View in: PubMed
    Score: 0.194
  4. Dhasmana S, Dhasmana A, Narula AS, Jaggi M, Yallapu MM, Chauhan SC. The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sci. 2022 Jan 01; 288:120156.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support